Expanding the role of SETD5 haploinsufficiency in neurodevelopment and neuroblastoma
- 3 August 2020
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 67 (11), e28376
- https://doi.org/10.1002/pbc.28376
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Genetic susceptibility to neuroblastomaCurrent Opinion in Genetics & Development, 2017
- Setd5is essential for mammalian development and co-transcriptional regulation of histone acetylationDevelopment, 2016
- Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndromeEuropean Journal of Human Genetics, 2014
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric OsteosarcomaCell Reports, 2014
- Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical regionAmerican Journal of Medical Genetics Part A, 2013
- The epidemiology of hepatoblastomaPediatric Blood & Cancer, 2012
- Cancer in Children with Nonchromosomal Birth DefectsThe Journal of Pediatrics, 2012
- The contrasting age‐incidence patterns of bone tumours in teenagers and young adults: Implications for aetiologyInternational Journal of Cancer, 2011
- Congenital abnormalities and childhood cancerCancer, 2005
- The SET-domain protein superfamily: protein lysine methyltransferasesGenome Biology, 2005